Background: Apicomplexan parasites, including Cryptosporidium, possess organelles associated with host cell invasion. Results: A chicken-derived monoclonal antibody inhibited host cell invasion by C. parvum. The corresponding antigen, which localizes to the apical region of the parasite, was identified as elongation factor-1␣ (EF-1␣). Conclusion: EF-1␣ mediates cryptosporidial cytoskeletal complex critical for host cell invasion. Significance: The findings suggest that cryptosporidial EF-1␣ could serve as a novel anti-infective target antigen.
against Eimeria acervulina (Protozoa, Apicomplexa) and demonstrated that one such mAb (6D-12-G10) recognized the conoid of E. acervulina sporozoites and significantly inhibited sporozoite invasions of T lymphocytes in vitro (18) . Furthermore, mAb 6D-12-G10 showed high cross-reactivity with related parasites, including other Eimeria spp., Neospora caninum, Toxoplasma gondii, Cryptosporidium parvum, and C. muris (19, 20) . Indirect immunofluorescent assay revealed that mAb 6D-12-G10 is reactive only with the apical region of the zoites. These results provide convincing evidence that the antigen recognized by mAb 6D-12 G10 is a highly conserved epitope and thus a novel target vaccine antigen against many infections caused by apicomplexa parasites including Cryptosporidium.
In the present study, we show evidence that the epitope recognized in C. parvum by mAb 6D-12-G10 was a protein of ϳ48 kDa related to cytoskeletal function. Immunofluorescence staining and Western blotting patterns of mAb 6D-12-G10 were similar to, yet clearly distinct from, those of known cytoskeletal proteins. Immunoelectron microscopy confirmed the apical cytoskeletal location of the antigen recognized by 6D-12-G10. MALDI-TOF/MS and LC-MS/MS analyses of the target identified the protein as C. parvum elongation factor-1␣ (EF-1␣).
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EXPERIMENTAL PROCEDURES
Parasites-C. parvum oocysts, strain HNJ-1, were originally obtained from the feces of a patient in Japan (21) and passaged in severe combined immunodeficiency mice at Osaka City University, Japan. Oocysts were purified by sugar flotation and stored at 4°C in phosphate-buffered saline (PBS), pH 7.2, for not more than 1 month before use or before freeze-drying for gel electrophoresis. C. parvum sporozoites and merozoites were prepared as previously reported (20) .
Antibodies-Cell culture supernatant containing mAb 6D-12-G10 was used (18) . Rabbit anti-actin polyclonal Ab against a synthetic peptide from the NH 2 -terminal region (A5060, Sigma), mouse anti-myosin mAb against the myosin heavy chain polypeptide of human uterus smooth muscle extract (M7786, Sigma), mouse anti-␣-tubulin mAb against the COOH-terminal region of ␣-tubulin isoform of sea urchin sperm axonemes (T5168, Sigma), mouse anti-␤-tubulin mAb against purified rat brain tubulin (T4026, Sigma), and mouse anti-␥-tubulin mAb against a synthetic peptide from the NH 2 -terminal region (T6557, Sigma) were used. All Abs were used at 1:100, except for anti-␣-tubulin Ab (used at 1:1,000). A rabbit anti-C. parvum antiserum was raised against soluble antigens and recognized many life cycle stages of the parasite, including oocyst walls and surface membranes of immature meronts, sporozoites, and merozoites (22) . This Ab was used to detect the parasites in cell invasion inhibition assay, as described below.
Western Blot Analysis-One-dimensional SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting were performed as previously reported (20) , except that horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (1:10,000, Sigma) or HRP-conjugated goat anti-rabbit IgG (1:5,000, Sigma) were used as secondary Abs. As a control, purified normal rabbit IgG (Sigma) or normal mouse IgG (Sigma) (at a 1:1,000 dilution) was used.
Pronase Digestion-A whole sporozoite extract was prepared by sonication of C. parvum in PBS (20) . Twenty micrograms of the extract was treated with Pronase (Sigma) or vehicle control at a 1:1 (w:w) ratio and digested at 37°C for 2 h in 100 mM Tris-HCl (Nacalai Tesque) and 10 mM CaCl 2 (Sigma), pH 8.0, as previously described (23) . The samples were analyzed by Western blotting using mAb 6D-12-G10 as described above.
To confirm reactivity against the Pronase-digested extract, the Pronase-or mock-digested sporozoite extract (50 l/well at 50 g/ml) was coated onto flat-bottomed 96-well an enzymelinked immunosorbent assay (ELISA) plates (BD Biosciences). Nonspecific binding was blocked by incubating the plates with 1% bovine serum albumin in PBS for 1 h at 37°C. mAb 6D-12-G10 or control (purified normal chicken IgG (1:1,000, Sigma)) was diluted in Iscove's modified Dulbecco's medium, and distributed at 50 l/well. Following incubation at 37°C for 1 h, plates were washed 3 times with PBS containing 0.05% Tween 20 (PBST) and then incubated at 37°C for 1 h with 50 l/well of HRP-labeled rabbit anti-chicken IgG F(abЈ) 2 fragment (1:1,000, Cortex Biochemistry, CA). Plates were again washed 3 times with PBST and developed using TMB microwell peroxidase substrate (KPL) according to the manufacturer's instructions. The single wavelength absorbance was measured at 450 nm by an ELISA plate reader (ARVO-2, PerkinElmer Life Sciences). The mean optical density value was calculated for reactions performed in triplicate. Statistical analysis was performed using Student's t test; p values of 0.05 or below were considered significant.
Indirect Immunofluorescence Assay-C. parvum sporozoites were dried on glass slides as previously reported (20) , fixed in absolute methanol, and stored at Ϫ80°C until use. All subsequent steps were performed at room temperature. To extract the detergent-soluble proteins associated with the surface membrane of sporozoites, the cells were permeabilized by incubation for 20 min in PBS containing 0, 0.1, or 1% Triton X-100 (Sigma). After washing 3 times with PBS, the slides were incubated for 40 min with 50 l of mAb 6D-12-G10 or negative control (purified normal chicken IgG (Sigma) diluted in Iscove's modified Dulbecco's medium). The slides were washed 3 times with PBST, and then incubated for 30 min with 50 l of fluorescein isothiocyanate (FITC)-conjugated rabbit antichicken IgG (1:1,000, Sigma). After washing with PBST, the slides were mounted with 50% glycerol (Nacalai Tesque) in PBS and examined using a epifluorescence microscope (ECLIPS E600, Nikon).
Indirect immunofluorescence assay of cytoskeletal antigens of C. parvum sporozoites was conducted as reported previously (24) with the following modifications. Permeabilization was performed using in 0.1% Triton X-100, and reactions were performed using anti-actin, anti-myosin, anti-␣-tubulin, anti-␤-tubulin, and anti-␥-tubulin as primary Abs. Controls were performed using purified normal rabbit IgG (Sigma) or normal mouse IgG (Sigma) (1:1,000). Secondary Abs were consisted of FITC-conjugated goat anti-rabbit IgG (Sigma) or FITC-conjugated goat anti-mouse IgG F(abЈ) 2 fragment (Sigma) diluted 1:100.
Two-dimensional Polyacrylamide Gel ElectrophoresisTwo-dimensional PAGE was performed using the Protean IEF Cell (Bio-Rad) according to the manufacturer's protocol. Briefly, 1.0 ϫ 10 9 freeze-dried C. parvum oocysts were dissolved in 1.0 -2.0 ml of rehydration/sample buffer containing 8 M urea, 2.0% CHAPS, 50 mM dithiothreitol, 0.2% Bio-lyte 3/10, and 0.001% bromphenol blue. The solution was sonicated in an ice bath (Taitec, Saitama) and centrifuged at 600 ϫ g for 5 min; the supernatant was aliquoted and stored at Ϫ80°C until use. The protein concentration was determined using the Coomassie Blue Assay Kit (Pierce). For first-dimension electrophoresis, ReadyStrip TM pH 3-10 IPG strips (7 cm, Bio-Rad) were rehydrated for 12 h with 100 l of 200 g/ml of oocyst extract. Focusing conditions were 20 min at 250 V, followed by voltage ramping to 4,000 V over a 2-h interval and electrophoresis for 2.5 h at 4,000 V at 20°C. For second-dimension electrophoresis, proteins were resolved on 4% stacking, 12% gradient SDS-PAGE gels at 200 V. Second-dimension gels were blotted to PVDF membrane (Immobilon Transfer Membranes, Millipore) and analyzed by Western blotting as described above. For protein identification, the gels were stained using the Silver Stain II Kit (Wako).
Immunoelectron Microscopy-C. parvum sporozoites (1.0 ϫ 10 7 ) were excysted as previously reported (20) and resuspended in 400 l of RPMI 1640 medium. The resulting suspension was applied (at 5.0 l/grid) to carbon-stabilized 200-mesh nickel grids covered with thin collodion film (Nissin EM) and allowed to settle for 20 min in a humidity chamber. Excess fluid was removed and the grids were air-dried. Parasites were stained with mAb 6D-12-G10 or normal chicken IgG (Sigma), washed with PBS, incubated with 10-nm colloidal gold-labeled rabbit anti-chicken IgG (EY Laboratories), washed 3 times with PBS and water, stained for 30 s with 2.0% phosphotungstic acid, pH 7.5 (TAAB Laboratories), and examined using a Hitachi H-7500 electron microscope (Hitachi Science Systems). In some experiments, the sporozoites were treated with 0.1% Triton X-100 in RPMI 1640 medium for 5-10 min at 4°C, fixed in 0.1% glutaraldehyde (TAAB Laboratories) and 2.0% paraformaldehyde (Merck) in 0.1 M phosphate buffer (PB) at 4°C for 4 -6 days, and examined by immunoelectron microscopy via the above procedure.
For immunolocalization of the antigen recognized by mAb 6D-12-G10, excysted C. parvum sporozoites and merozoites cultured in human colonic tumor cells (HCT-8, Dainippon Pharmaceutical) (20) were fixed with 0.05% glutaraldehyde and 2.0% paraformaldehyde in 0.1 M PB at 4°C for 30 min, washed in ice-cold PB, dehydrated in a graded series of cold ethanol solutions, and embedded in LR White resin (London Resin). Thin sections were cut and mounted on nickel grids (Nissin EM); the grids then were blocked with 0.1 M glycine (Nacalai Tesque) in PBS followed by 1.0% nonfat dry milk in PBS. Following staining (overnight at 4°C) with mAb 6D-12-G10 or normal chicken IgG (Sigma) and colloidal gold-labeled secondary Ab as above, grids were incubated for 20 min in 1.0% uranyl acetate (TAAB Laboratories) and examined as described above.
Invasion Inhibition Assay-C. parvum oocysts were treated with 10% sodium hypochlorite (Wako) in PBS at 4°C for 15 min to excyst sporozoites and washed 2 times with cold PBS. Treated oocysts (1.0 ϫ 10 5 ) then were mixed with 200 l of one of the following: mAb 6D-12-G10, an irrelevant mAb (8D-2) raised against E. acervulina and known not to react with Cryptosporidium parasites (20) ; or normal chicken IgG (Sigma) and only culture medium. mAbs 6D-12-G10 and 8D-2 were present at approximately equal IgG concentrations in the hybridoma supernatants. Parasite/mAb mixtures were incubated with confluent monolayers of HCT-8 cells in perfusion chambers (CoverWell TM , Grace Bio-Labs) at 37°C for 2 h in 5% CO 2 . Following incubation, the cells were washed 3 times with RPMI 1640 containing 10% FBS (Invitrogen) as culture medium, incubated for an additional 22 h, and fixed with acetone for 10 min. The slides were blocked with 10% normal goat serum (Sigma) and stained with rabbit anti-C. parvum antiserum (1:1,000) plus Alexa Fluor 488-conjugated goat anti-rabbit IgG (HϩL) (1:1,000, Molecular Probes) as a secondary antibody. The number of intracellular zoites was counted in 6.6-mm 2 fields per chamber at ϫ400 magnification using a fluorescent microscope (Nikon). The percent inhibition of infection was calculated by the following formula: (1 Ϫ [No. zoites after 6D-12-G10, 8D-2 mAb, or normal chicken IgG treatment/No. zoites after culture medium]) ϫ 100%. The mean percent inhibition was calculated based on four replicates each, and values from each treatment were compared using Student's t test (as above).
Protein Identification-The protein antigen recognized by mAb 6D-12-G10 was identified by NH 2 -terminal amino acid sequencing in combination with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) and liquid chromatography/tandem mass spectrometry (LC-MS/MS). Briefly, for NH 2 -terminal sequencing, proteins in a C. parvum oocyst extract were separated by twodimensional PAGE, blotted to PVDF, and stained with Coomassie Blue (Bio-Rad). The visible spot in the 48-kDa region was excised from the membrane, and the resulting protein was subjected to automated Edman degradation using the Procise 494 HT (Applied Biosystems). For MALDI-TOF/MS and LC-MS/MS, the 48-kDa spot was separated by two-dimensional PAGE as described above, excised from the gel, and stored at Ϫ20°C until use. Trypsin (Promega) digestion was carried out as described by Shevchenko et al. (25) . The tryptic digest was adsorbed to a C-18 reverse phase matrix and eluted with 60% acetonitrile containing 0.2% TFA. MALDI-TOF/MS was performed using a Voyager-DE STR instrument (Applied Biosystems); the observed m/z values were analyzed using ProFound software (Proteomic Solutions) and peptide mass fingerprints were queried in the NCBInr database. For LC-MS/MS, the tryptic digest was resolved by high-performance liquid chromatography on a C-18 column (0.1 ϫ 50 mm; Michrom BioResources) coupled to a Q-TOF2 mass spectrometer equipped with a nanoelectrospray ionization source (Waters Micromass). Positive ion tandem mass spectra were measured and the data were used to search the non-redundant NCBI protein database using the MASCOT software (Matrix Science).
Cloning and Sequencing of C. parvum EF-1␣-encoding GeneTotal RNA for C. parvum oocysts was isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. To permit cloning of the full-length transcript encoding C. parvum EF-1␣, 5Ј and 3Ј rapid amplification of cDNA ends was performed using the SMARTer RACE cDNA Amplification Kit (Takara) using primers CpEF1aRA-R1 (5Ј-CTG GGG CAT CAA TGA CAG TGT AGT GGT A-3Ј) for the 5Ј end and CpEF1aRA-F1 (5Ј-TGT TAC CTT CGC TCC AGC TGG TGT TAC C-3Ј) for the 3Ј end. The putative signal sequence and membrane topology of the predicted C. parvum EF-1␣ protein were analyzed using the prediction server SignalP version 4.1 (26) and the TMHMM Server version 2.0, respectively. Sequence analysis of the rapid amplification of cDNA ends products permitted identification and cloning of the complete coding region of the C. parvum EF-1␣-encoding transcript.
Expression of C. parvum EF-1␣-Single-stranded cDNA for C. parvum mRNA was prepared using the Takara RNA PCR Kit (AMV) version 3.0 (Takara) following the manufacturer's instructions. The recombinant C. parvum EF-1␣ protein was produced by Bex Co. Ltd. Briefly, the open reading frame (ORF) encoding C. parvum EF-1␣ was amplified from cDNA from C. parvum oocysts by PCR with a pair of primers (forward, EF1␣-BamHI-F (5Ј-ATT ATT GGA TCC GAT GGG TAA GGA AAA GAC TCA-3Ј), reverse, EF1␣-XhoI-R (5Ј-ATT ATT CTC GAG TTA CTT CTT CTT GGA AGT GG-3Ј)) that provided flanking BamHI and XhoI restriction sites for cloning (using a DNA ligation kit) into the pET-47b(ϩ) vector (Novagen). The sequence of the C. parvum EF-1␣-encoding construct was confirmed using internal primers. The resulting plasmid was transformed into competent cells of Escherichia coli strain BL21 (Takara) following standard methods. The C. parvum EF-1␣ was successfully expressed with a polyhistidine tag in E. coli and purified as soluble protein from bacterial cultures using ProBond TM resin (Invitrogen). Purified recombinant protein was electrophoresed on SDS-PAGE gel and detected as an ϳ50 kDa fusion protein. Reactivity with mAb 6D-12-G10 was assessed by Western blotting. 376 ) suggested based on predicted antigenicity were synthesized on a ABI433A peptide synthesizer (Applied Biosystems) by Scrum Inc. Peptides were deprotected and lyophilized, and their purity was assessed using an Alliance HPLC System (Waters Corporation) and MALDI-TOF/MS. The reactivity of mAb 6D-12-G10 with these peptides was assessed by ELISA as described above.
Synthesis of C. parvum EF-1␣ Peptides and Anti-peptide Ab
A polyclonal antibody against C. parvum EF-1␣ was generated by Scrum Inc. using the synthetic peptide, 217 DTMEPPKRPTDKPL 230 , with the highest antigenicity as predicted by the Lasergene DNA program. Briefly, this peptide was coupled to keyhole limpet hemocyanin and administered in rabbit by serial immunization at 0.25 mg/dose (initial intradermal injection in complete Freund's adjuvant, followed by four subcutaneous booster injections in incomplete Freund's adjuvant at intervals of 2 weeks). Immune sera were collected on day 63, i.e. 1 week after the final booster shot. Serum reactivity against C. parvum was determined by Western blotting.
RESULTS
Pronase Sensitivity of the Epitope Recognized by mAb 6D-12-G10-In our initial attempt to characterize the antigen recognized by mAb 6D-12-G10, soluble sporozoites were disrupted by sonication; the soluble protein fraction was treated with Pronase or vehicle control and analyzed by Western blotting. As shown in Fig. 1 , a 48-kDa band was detected in the mock-digested sample, but was not observed after Pronase treatment. Furthermore, similar Pronase sensitivity was observed via ELISA: the optical density value of antigens treated with Pronase (0.033 Ϯ 0.027) was significantly decreased compared with those of mock-digested (1.201 Ϯ 0.213) and untreated (1.309 Ϯ 0.228) C. parvum antigens. Fig. 2A shows immunofluorescence staining of C. parvum sporozoites treated with 0.1% Triton X-100. Notably, 20 min pre-treatment of whole cells with 0, 0.1, or 1% Triton X-100 did not alter the reactivity with mAb 6D-12-G10, and positive reactions were observed only at the apical region of the sporozoites.
Reactivity of mAb 6D-12-G10 with Triton X-100-treated Sporozoites-
Comparison of mAb 6D-12-G10 with Other Cytoskeleton-specific Abs-Our previous results demonstrated that the antigen recognized by mAb 6D-12-G10 was located in the apical cytoskeleton of E. acervulina sporozoites (18) . Therefore, we examined the location of the cross-reacting antigen of C. parvum in relationship to that of other cytoskeletal proteins by indirect immunofluorescence and Western blot analysis. Abs against actin, myosin, ␤-tubulin, and ␥-tubulin stained only the apical region of the sporozoites (Fig. 2, C, E, I , and K). The antigenic structures recognized by the individual Abs were localized as follows: anti-actin Ab, within the internal portion of the apical region; anti-myosin Ab, at the tip of the apical region; anti-␤-and ␥-tubulin Abs, at the surface of the apical region; and anti-␣-tubulin Ab, at the apical region and along the central microtubules (Fig. 2, C, E, I , K, and G, respectively). Labeling by the mAb 6D-12-G10 was similar with that seen with the anti-␤-tubulin and anti-␥-tubulin Abs. In control assays, normal rabbit and mouse IgG did not provide labeling (data not shown). In Western blot analyses, mAb 6D-12-G10 and Abs against actin and ␣-tubulin reacted with protein bands of ϳ48, 42, and 50 kDa, respectively (Fig. 3) . None of the other cytoskeleton-specific Abs or controls detected individual bands in Western blots. Immunoblot analysis following two-dimensional PAGE resolution of C. parvum proteins revealed that the 48-kDa band recognized by mAb 6D-12-G10 was focused at an isoelectric point (pI) of 9.74 (Fig. 4A) . The actin and ␣-tubulin of C. parvum were detected at pI values of 5.93 and 6.24, respectively (Fig. 4, B and C) . 
Immunoelectron Microscopy of the 6D-12-G10 mAb-reactive
Antigen at the Apical Region of Zoites-Immunoelectron microscopy using the 6D-12-G10 mAb with C. parvum sporozoites revealed localization of gold particles at the apical region of the parasite surface (Fig. 5A) . After treatment of the sporozoites with 0.1% Triton X-100, increased numbers of gold particles were observed across a larger area of the apical region (Fig. 5B) . However, the internal organelles (central microtubules and micronemes) were not labeled by mAb 6D-12-G10. Furthermore, mAb 6D-12-G10-targeted gold particles were localized below the inner membrane of the apical region as well as on the surface membrane. In a control assay, normal chicken IgG did not react with the untreated or Triton X-100-treated sporozoites (data not shown).
Immunoelectron microscopy of longitudinal sections of C. parvum sporozoites and merozoites using mAb 6D-12-G10 revealed localization of gold particles close to the surface membrane at the apical region; labeling was not observed within the internal organelles (rhoptries and micronemes) (Fig. 6, A and  B) . On sporozoites, gold particles were observed between the surface membranes and beneath the inner membrane (Fig. 6C) . Gold particles were not present in the immature trophozoites (Fig. 6D ), but were observed at the apical region as well as the surface regions and beneath the inner membrane of mature merozoites (Fig. 6, E and F) . In control assays, normal chicken IgG did not react with sporozoites, trophozoites, or merozoites.
mAb 6D-12-G10 Blocking of Host Cell Invasion by C. parvumThe 6D-12-G10 mAb was originally identified by its ability to block E. acervulina sporozoite invasion of chicken CD8 ϩ T lymphocytes (18) . Therefore, we next assessed the ability of this mAb to inhibit host cell invasion by C. parvum. As shown in Fig.  7 , mAb 6D-12-G10 blocked C. parvum infection of HCT-8 cells by 80.9% compared with culture medium. In a control assay, normal chicken IgG, and mAb 8D-2 (a chicken mAb that reacts with E. acervulina but not C. parvum) inhibited invasion by 7.9 and 51.2%, respectively. In this assay, mAb 8D-2 serves as an appropriate control because both 8D-2 and 6D-12-G10 are derived as cell culture supernatants from confluent chicken hybridomas. Although the culture supernatant compared with fresh culture medium (only culture medium or normal chicken IgG) could reduce the viability itself of HCT-8 host cells resulting in a decrease of the infection (data not shown), the greater inhibition by mAb 6D-12-G10 compared with 8D-2 was significant (p Ͻ 0.01).
Identification of EF-1␣ as the Protein Recognized by mAb 6D-12-G10-Silver staining of the two-dimensional PAGE-derived immunoblot confirmed that the 48-kDa protein recognized by mAb 6D-12-G10 ran as a single spot at basic pH (Fig.  8A) . NH 2 -terminal amino acid sequence analysis of the spot recovered from the two-dimensional PAGE-blotted membrane of the C. parvum extract was unsuccessful, suggesting that the NH 2 terminus was blocked (data not shown). Tryptic peptides derived from the 6D-12-G10 mAb-reactive protein were analyzed by MALDI-TOF/MS and LC-MS/MS. The results of database searching of the tandem mass spectra with the Mascot Search Program are shown in Tables 1 and 2 . MALDI-TOF/MS and LC-MS/MS demonstrated that the tryptic peptides provided, respectively, 40 -49 and 55% sequence coverage of the predicted C. parvum EF-1␣ protein. The extent of the coverage by LC-MS/MS is indicated in Fig. 8B . Based on these sequence alignments, the probability-based Mowse score was 794 for EF-1␣ and 135 for the C. parvum extracellular protein with a signal peptide (CpCCP2), the second most likely identification (Table 2) . However, the theoretical molecular mass (184.41-kDa) and pI (6.36) of CpCCP2 were inconsistent with the observed values, therefore suggesting that EF-1␣ is the protein recognized by mAb 6D-12-G10.
Cloning of C. parvum EF-1␣-encoding Gene and Validation of Reactivity of the Recombinant Protein with mAb 6D-12-G10-
Sequence analysis of the rapid amplification of cDNA ends products permitted cloning of a 1,308-bp C. parvum transcript encoding EF-1␣. All sequences were identical with those previously reported in GenBank TM (accession numbers CAD98440 and AAC02806), and included a 435-codon ORF flanked by ϳ100 and 300 bp of non-coding 5Ј and 3Ј sequences, respectively. The encoded protein has a predicted molecular weight of 48.16 ϫ 10 3 and a pI of 8.95, and but is not expected to harbor signal peptide or transmembrane domains. However, as assayed by Western blotting, mAb 6D-12-G10 showed no reactivity with the recombinant C. parvum EF-1␣ expressed in E. coli (data not shown).
mAb 6D-12-G10 Detection of Synthetic Peptides of C. parvum EF-1␣-By ELISA, mAb 6D-12-G10 did not show specificity for any of 6 synthetic peptides generated on the basis of the EF-1␣ protein sequence (data not shown). Thus, the epitope recognized by this mAb was not provided by these amino acid sequences. A polyclonal anti-peptide Ab raised against the DTMEPPKRPTDKPL peptide detected a protein in C. parvum extracts that was indistinguishable (in molecular weight and pI) from that recognized by mAb 6D-12-G10 (Fig. 9) . Unfortu- nately, this anti-peptide Ab did not show any specific reactivity with C. parvum sporozoites by immunofluorescence staining (data not shown). Probably, the peptide as a epitope might be masked by carbohydrate chain or protein folding. These results indicate that the C. parvum antigen recognized by mAb 6D-12-G10 is EF-1␣, and the post-translational modification at the step in protein biosynthesis specific for the protozoan C. parvum, but not E. coli, could be required for generation of the epitope recognized by mAb 6D-12-G10.
DISCUSSION
As demonstrated here, the previously described mAb 6D-12-G10, which detects an apical complex antigen of E. acervulina, a The Mowse score is calculated as -log 52(P), where P is the probability that the observed match is a random event.
FIGURE 9. One-and two-dimensional Western blot analyses of C. parvum antigens using antibody against C. parvum EF-1␣ peptide (DTMEPPKRPTDKPL) (A and B, respectively). Lane 1 in A, molecular mass standards. Arrows indicate band (lane 2 in A) or spot detected by the antibody (Fig. B) . Lane 3 in A, mAb 6D-12-G10.
identified a 48-kDa apical membrane protein of C. parvum. Furthermore, mAb 6D-12-G10 reactivity remained in the extract of the Triton X-100-treated C. parvum sporozoites, suggesting that the antigen recognized by mAb 6D-12-G10 may be associated with the cytoskeleton protein of C. parvum sporozoites but not surface membrane. The ultrastructure of Cryptosporidium zoites, including the architecture and components of the cytoskeleton, are not fully understood. It was reported that C. parvum sporozoites lacked structures resembling conoids in zoites (27) and that C. parvum sporozoites differed from other apicomplexan parasites in their cytoskeletal structure (24) . Therefore, to accurately discern the localization of the mAb 6D-12-G10-reactive antigen in C. parvum sporozoites, we compared the mAb reactivities by immunofluorescence and Western blot analysis with those of commercial Abs raised against known cytoskeleton components. All of the cytoskeletal antigens were found to be present in C. parvum sporozoites, with actin, myosin, and ␤-and ␥-tubulins localized only to the anterior portion of the parasites. However, only the anti-actin and anti-␤-tubulin Abs were reactive by Western blotting, suggesting that the conformation of the epitopes recognized by the anti-myosin, anti-␣-tubulin, and anti-␥-tubulin Abs may be altered by the solubilization conditions used for gel electrophoresis. In our hands, the reactivity of mAb 6D-12-G10 against C. parvum was similar to that of anti-␤-tubulin and anti-␥-tubulin Abs as assayed by immunofluorescence, but the antigen recognized by the mAb was distinct from actin and ␣-tubulin by Western analysis.
Previously, the mAb 6D-12-G10 was shown to recognize the conoid of E. acervulina sporozoites (18) . However, in the present study, the mAb 6D-12-G10-reactive antigen was ultrastructurally localized both to the surface and underneath the membrane of the parasite in the apical region; the surface-localized antigen was not extracted by Triton X-100 treatment. Furthermore, this antigen was expressed in a stage-specific manner, being present in sporozoites excysed from oocysts and merozoites within mature meronts, but not in immature trophozoites. Thus, these findings suggest that the antigen recognized by mAb 6D-12-G10 is a protein associated (directly or indirectly) with the cytoskeleton of the apical complex on C. parvum invasive zoites, and with the conoid of E. acervulina. These structures are known to be related to host cell invasion, a function not ascribed to the cytoskeletons itself.
Protein structural analyses identified the 48-kDa antigen as C. parvum EF-1␣. To date, only one study has described the cloning and sequencing of a cryptosporidial EF-1␣-encoding gene, although the details of the function or ultrastructural location of the encoded protein were not reported (28) . In general, EF-1␣ is highly conserved and ubiquitously expressed in all eukaryotic cells (29 -32) . Functionally, EF-1␣ transfers aminoacylated tRNAs to the ribosome A site in a GTP-dependent reaction (33) . In addition, EF-1␣ appears to have a number of other functions associated with cell growth, motility, protein turnover, and signal transduction (34, 35) , more recently DNA replication/repair protein networks (36) and apoptosis (37) . Some among these previous studies have demonstrated that EF-1␣ can be bound by actin filaments or microtubules as one function (38 -44) . In particular, EF-1␣ was reported to be a cytoskeleton-binding protein and to play a role in regulating the assembly and cross-linking of actin filaments and microtubules. The results of the present study, combined with those of our previous publication (18) , suggest that EF-1␣ associates with the cytoskeleton at the apical region, forming an essential component of the invasion apparatus of the parasite. This hypothesis is consistent with the demonstration by other laboratories that host cell invasion by Apicomplexan parasites is an active process mediated by the cytoskeleton of the parasite, and that the host cell need not play an active role in parasite uptake (45, 46) . The distinct localization of EF-1␣ between C. parvum and E. acervulina zoites might be related to differences in ultrastructure or mechanism of invasion, given that C. parvum sporozoites infect only epithelial cells, whereas Eimeria sporozoites invade both T lymphocytes and intestinal epithelial cells.
Further analysis is needed to clarify the molecular role of EF-1␣ during parasite attachment and invasion of host cells. However, considering that the mAb 6D-12-G10 reactive antigen is highly conserved among Apicomplexan genera, EF-1␣ warrants investigation as a candidate anti-infective vaccine antigen.
